Generation Bio Co. — Investor Relations & Filings
Generation Bio Co. is a biotechnology company developing therapeutics for T cell-driven autoimmune diseases. The company's platform utilizes proprietary cell-targeted lipid nanoparticles (ctLNPs) to selectively deliver small interfering RNA (siRNA) to T cells. This approach is designed to potently silence specific genes and modulate the function of autoreactive T cells responsible for tissue and organ damage. The technology aims to provide redosable treatments with genetic precision and tunable pharmacology, while sparing the broader immune system from off-target effects.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| SCHEDULE 13G/A Filing | 2026-02-17 | English | |
| SCHEDULE 13G/A Filing | 2026-02-12 | English | |
| SCHEDULE 13G/A Filing | 2026-02-11 | English | |
| 4 - Generation Bio Co. (0001733294) (Issuer) | 2026-02-10 | English | |
| 4 - Generation Bio Co. (0001733294) (Issuer) | 2026-02-09 | English | |
| 4 - Generation Bio Co. (0001733294) (Issuer) | 2026-02-09 | English |
Browse filings by year
8 yearsMarket data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
BIOMM SA
Develops and manufactures biopharmaceuticals and biosimilar…
|
— | BR | Manufacturing |
|
BiomX Inc.
Clinical-stage company developing phage therapies to target…
|
PHGE | US | Manufacturing |
|
BIONEERCORPORATION
Develops and manufactures molecular biology products for re…
|
064550 | KR | Manufacturing |
|
BioNTech SE
Biotechnology company developing immunotherapies for cancer…
|
BNTX | DE | Manufacturing |
|
BioNxt Solutions Inc.
Clinical-stage developer of next-generation drug formulatio…
|
BNXT | CA | Manufacturing |
|
Biophage Pharma Inc.
Developing innovative phage-based therapies for antibiotic-…
|
BIPMF | CA | Manufacturing |
|
BioPorto
An in vitro diagnostics company specializing in biomarkers …
|
BIOPOR | DK | Manufacturing |
|
BIO-RAD LABORATORIES, INC.
Develops and manufactures products for life science and cli…
|
BIO | US | Manufacturing |
|
Biosergen AB
Develops drugs to treat severe and resistant invasive funga…
|
BIOSGN | SE | Manufacturing |
|
Biosino Bio-Technology and Science Incorporation
Major high-tech manufacturer of in-vitro diagnostic (IVD) p…
|
8247 | HK | Manufacturing |
Generation Bio Co. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34688/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34688 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34688 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34688 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34688}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Generation Bio Co. (id: 34688)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.